Tumor suppressor KEAP1 promotes HSPA9 degradation, controlling mitochondrial biogenesis in breast cancer
Cell Reports · 2024-07 · 43 (7) · 114507
DOI: 10.1016/j.celrep.2024.114507 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2024-07. Verfasst von Bing Han und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Medical Oncology, Harbin Medical University Cancer Hospital, Harbin Medical University, 150 Haping Road, Harbin, Heilongjiang Pr…. Hauptthemen laut MEDLINE: Kelch-Like ECH-Associated Protein 1, Breast Neoplasms, Ubiquitination, Cell Proliferation. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Ministry of Education of the People's Republic of China, Harbin Medical University Cancer Hospital.
Abstract (Originalsprache)
The oxidative-stress-related protein Kelch-like ECH-associated protein 1 (KEAP1) is a substrate articulator of E3 ubiquitin ligase, which plays an important role in the ubiquitination modification of proteins. However, the function of KEAP1 in breast cancer and its impact on the survival of patients with breast cancer remain unclear. Our study demonstrates that KEAP1, a positive prognostic factor, plays a crucial role in regulating cell proliferation, apoptosis, and cell cycle transition in breast cancer. We investigate the underlying mechanism using human tumor tissues, high-throughput detection technology, and a mouse xenograft tumor model. KEAP1 serves as a key regulator of cellular metabolism, the reprogramming of which is one of the hallmarks of tumorigenesis. KEAP1 has a significant effect on mitochondrial biogenesis and oxidative phosphorylation by regulating HSPA9 ubiquitination and degradation. These results suggest that KEAP1 could serve as a potential biomarker and therapeutic target in the treatment of breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Breast Medical Oncology, Harbin Medical University Cancer Hospital, Harbin Medical University, 150 Haping Road, Harbin, Heilongjiang Province 150040, China.
- Research Center for Pharmacoinformatics (The State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), College of Pharmacy, Harbin Medical University, 157 Baojian Road, Harbin, Heilongjiang Province 150081…
- Key Laboratory of Preservation of Human Genetic Resources and Disease Control in China (Harbin Medical University), Ministry of Education, Harbin, Heilongjiang Province 150081, China.
- Department of Oncology, The First Affiliated Hospital of Harbin Medical University, 23 Youzheng Street, Harbin, Heilongjiang Province 150001, China. Electronic address: cxs1978@ems.hrbmu.edu.cn.
- State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Department of Biopharmaceutical Sciences, College of Pharmacy, Harbin Medical University, Harbin, Heilongjiang Province 150081, China. Electronic ad…
- Department of Breast Medical Oncology, Harbin Medical University Cancer Hospital, Harbin Medical University, 150 Haping Road, Harbin, Heilongjiang Province 150040, China; Key Laboratory of Preservation of Human Genetic…
Förderung
- National Natural Science Foundation of China
- Ministry of Education of the People's Republic of China
- Harbin Medical University Cancer Hospital
- Harbin Medical University
Zitieren
APA
Han, B., Zhen, F., Sun, Y., Sun, B., Wang, H. Y., Liu, W., Huang, J., Liang, X., Wang, Y. R., Chen, X. S., Li, S. J., & Hu, J. (2024). Tumor suppressor KEAP1 promotes HSPA9 degradation, controlling mitochondrial biogenesis in breast cancer. Cell Reports, 43(7), 114507. https://doi.org/10.1016/j.celrep.2024.114507
Vancouver
Han B, Zhen F, Sun Y, Sun B, Wang HY, Liu W, et al. Tumor suppressor KEAP1 promotes HSPA9 degradation, controlling mitochondrial biogenesis in breast cancer. Cell Reports. 2024;43(7):114507. doi:10.1016/j.celrep.2024.114507
BibTeX
@article{Han2024,
author = {Han, Bing and Zhen, Fang and Sun, Yue and Sun, Bin and Wang, Hong-Yi and Liu, Wei and Huang, Jian and Liang, Xiao and Wang, Ya-Ru and Chen, Xue-Song and Li, Shui-Jie and Hu, Jing},
title = {Tumor suppressor KEAP1 promotes HSPA9 degradation, controlling mitochondrial biogenesis in breast cancer},
journal = {Cell Reports},
year = {2024},
volume = {43},
number = {7},
pages = {114507},
doi = {10.1016/j.celrep.2024.114507}
}
EUVIMED